MOLOGIC LTD ‘HeadStart’ Initiative Award.

In collaboration with Professor Chris Brightling, NIHR Senior Investigator, Institute for Lung Health, Leicester and with the NIHR Diagnostic Evidence Cooperative (DEC), Newcastle, Mologic LTD was awarded a £100K Small Business Research Initiative (SBRI) phase 1 contract to further develop the Headstart test and provide robust evidence on clinical utility and cost-effectiveness of the test.

This test enables chronic obstructive pulmonary disease (COPD) patients to monitor their disease status at home for early indications of exacerbation. It will test the levels of key biomarkers in the urine, interpret them and identify imminent acute exacerbation and cause in 10 minutes.

For more details, click here to see the announcement from AHSN.

Download a pdf of the AHSN announcement by clicking on the image below: